Tonix Pharmaceuticals Announces Agreement to Acquire Infectious Disease R&D Facility to Accelerate Development of Vaccines and Antiviral Drugs

Go back to Tonix Pharmaceuticals Announces Agreement to Acquire Infectious Disease R&D Facility to Accelerate Development of Vaccines and Antiviral Drugs
TONIX PHARM HLDG (NASDAQ: TNXP) Delayed: 13.16 --0 (-0%)
Previous Close $13.16    52 Week High $7.95 
Open $13.16    52 Week Low $0.40 
Day High $13.16    P/E N/A 
Day Low $13.16    EPS $-5.33 
Volume 16